<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2020.88012</article-id><article-id pub-id-type="publisher-id">JBM-102271</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Treatment of Pathological Fractures of the Proximal Femur Due to Advanced Metastasis of Highly Malignant Tumors: A Clinical Controlled Study of Enterostenosis Reconstruction and Conservative Treatment
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Weikun</surname><given-names>Zheng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Junfen</surname><given-names>Tang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wende</surname><given-names>Xiao</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Weishan</surname><given-names>Cai</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Orthopedics, Guangzhou First People’s Hospital, Guangzhou, China</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>08</month><year>2020</year></pub-date><volume>08</volume><issue>08</issue><fpage>127</fpage><lpage>137</lpage><history><date date-type="received"><day>17,</day>	<month>July</month>	<year>2020</year></date><date date-type="rev-recd"><day>16,</day>	<month>August</month>	<year>2020</year>	</date><date date-type="accepted"><day>19,</day>	<month>August</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: To investigate whether different treatment methods have an impact on the quality of life and life span after fracture of patients with proximal femoral pathological fractures caused by advanced metastasis of highly malignant tumors. 
  Methods: Karnofsky performance status (KPS) and visual analogue score (VAS) were counted at the time of admission and 2 months after the treatments. Survival analysis was implemented to compare the median survival time and 6-month survival rate of the 2 groups. Musculoskeletal score (MSTS) was used to evaluate limb function in the surgical group at 2 months after the treatment. 
  Results: There was no significant difference in KPS score and VAS score between the two groups at the time of admission (p &gt; 0.05). At 2 months after treatment, the KPS score of the surgical group was higher than that of the conservative group (P &lt; 0.05), and the VAS score of the survivors of the surgical group was lower than that of the conservative group (P &lt; 0.05). Survival analysis showed that the median survival time and 6-month survival rate after fracture in the surgical group were higher than those in the conservative group (P &lt; 0.05). After 2 months of treatment, the average MTST score of survivors in the surgical group was 20.38 &#177; 0.9 (16 - 26 points). 
  Conclusion: Surgical intervention can benefit patients with pathological fractures of the proximal femur due to metastasis of highly malignant tumors in terms of quality of life and survival. Local tumor resection and endoparasitic replacement, which can be tolerated by most patients, can effectively reconstruct the limb function of these patients and restore their self-care ability.
 
</p></abstract><kwd-group><kwd>Malignant Tumors</kwd><kwd> Proximal Femoral Pathological Fracture</kwd><kwd> Endoparasitic Proximal Femoral Replacement</kwd><kwd> Conservative Treatment</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Advanced bone metastases from malignant tumors are very common, especially breast cancer, lung cancer, and gastric cancer. The common metastatic sites are the spine and lower extremities. Malignant bone metastases of the lower extremities mostly occur in the hips, especially the proximal femur, which is likely to cause the proximal femur pathological fractures [<xref ref-type="bibr" rid="scirp.102271-ref1">1</xref>], which are important factors for patients with poor prognosis [<xref ref-type="bibr" rid="scirp.102271-ref2">2</xref>]. At present, a large number of scholars [<xref ref-type="bibr" rid="scirp.102271-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref4">4</xref>] believe that as long as the patient’s life expectancy is not too short (&gt;2 months), surgical measures should be used to improve the quality of life; among them, endoparasitic proximal femoral replacement is an important technique [<xref ref-type="bibr" rid="scirp.102271-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref6">6</xref>]. However, in China, there are still a large number of patients and their families choose conservative treatment after pathological fracture of the proximal femur caused by metastases of tumor, especially the highly malignant tumors such as lung cancer and breast cancer. In addition, most of the domestic studies on patients with this type of fracture are descriptive studies of a single technique (such as a certain internal fixation method), and there is a lack of randomized controlled studies grouped by different treatments. This study conducted a retrospective case-control study on patients with proximal femoral pathological fractures caused by bone metastases from highly malignant tumors in our hospital from 2014 to 2019. The purpose of this retrospective case-control study was to: 1) investigate if different treatments have the impact on the quality of life and life span of patients after fracture, and to provide a scientific reference for the selection of clinical treatment and patient guidance; 2) evaluate the feasibility, effectiveness and safety of local tumor resection united endoparasitic proximal femoral replacement in reconstructing the limb function of such patients.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Clinical Data</title><p>Patients with pathological fractures of the proximal femur caused by bone metastases from malignant tumors treated in our hospital from 2014 to 2019 were observed. Inclusion criteria: 1) A clear history of primary malignant tumor; 2) Fracture, confirmed by auxiliary examination, of the proximal femur cause by slight external force, or no obvious external force is found; 3) CT, MR, bone Scanning clearly showed tumor cell invasion at the fracture site; 4) According to the evaluation of the Dutch model [<xref ref-type="bibr" rid="scirp.102271-ref7">7</xref>], the median survival time is more than 3 months; cardiopulmonary function evaluation, orthopedic evaluation and anesthesia evaluation shows the patient can tolerate the surgery 5) The patient or their families sign acceptance in the test consent form and was approved by the hospital ethics committee. Exclusion criteria: 1) The primary tumors are low-grade malignant tumors such as thyroid cancer and prostate cancer, and the expected survival period is too long; 2) The patient accompanying stroke, dementia, mental illness, etc. who can not cooperate with the investigator.</p></sec><sec id="s2_2"><title>2.2. Grouping and Intervention</title><p>All the research subjects and their families were informed of the detailed medical information base on the fracture situation and the oncology specialty. We analyzed the pros and cons of the operation for them, emphasizing the feasibility and necessity of the operation, but respecting the patient’s final treatment choice. Finally, 31 patients were included in the study and divided into 2 groups according to the final fracture treatment methods: 1) 14 patients in the surgical group were treated with tumor resection united endoparasitic reconstruction of the proximal femur (or combined acetabulum); 2) 17 patients in the conservative group. After the disease notification operation education, the patient’s willingness of conservative treatment was respected and conservative treatment was given, and a notice of illness was signed. All patients were simultaneously consulted in the oncology department or transferred to the oncology department opportunely for oncology treatment. According to the guide and the actual situation of the patient, strict and appropriate oncology treatment was performed. Surgical process: 1) local tumor resection. The patient was lying in the lateral position and a contralateral incision of the skin was made. Incision of fascia lata, entering from the gap between the posterior thigh muscle group and the lateral femoral muscle, splitting the gluteus maximus, cutting the external rotation muscle group, and cutting off the switch sac from the contralateral hip joint to expose the femoral head and tumor segment. Remove the femoral head and the tumor segment according to the preoperative, the distal range reaches more than 2 cm of normal tissue, and intraoperatively send frozen pathology was performed to confirm the complete excision of the tumor segment. Combined with the auxiliary preoperative examination, explore the acetabulum for tumor invasion. If the proximal femur is singly violated, the joint capsule can be retained. If the pelvis is violated at the same time, the joint capsule is removed, the pelvic tumor is scraped, and the bone cement is filled, and total hip replacement would be performed if necessary. If the soft tissue were invaded at the same time, it would be also removed, but try to keep the lateral muscle groups. 2) prosthesis installation. Measure the femur length, femur head size, etc. Depending on the completeness of acetabulum, a tumor-type double-action half-hip or total hip replacement would be adopted. After the trial installation of the prosthesis, the matching degree, the length of the lower extremities, the tension and the range of motion of the hip joint should be checked. The flexion, adduction and internal rotation must be stable. The bone cement is pre-injected into the medullary cavity, and the customized prosthesis is implanted and solidified by keeping the incline 10 - 15 forward. 3) Stabilize joints and reconstruct abduction. After the prosthesis is cured, if the joint capsule remains, it can be closed and sutured on the neck of the prosthesis to strengthen the stability of the hip joint. Fixing the remaining abductor and mid gluteal muscle stops at the trochanter. The lateral femoral muscle rotates to cover the fixed point, and its front is sutured with the external femoral muscle. If there is no remaining joint capsule, anti-rotation shoes and braces need to be born shortly after operation. Conservative treatment: patients in the conservative group were told to have a rest on the bed and local skin traction according to body weight was performed. We pay great attention to prevent the complications of and bed rest by strengthening precaution such as turning over and patting the back.</p></sec><sec id="s2_3"><title>2.3. Evaluation</title><p>All patients were followed up for life. Karnofsky performance status (KPS) and visual analogue score (VAS) were counted at the time of admission and 2 months after the treatments. Survival analysis, focus on death, was implemented to compare the median survival time and 6-month survival rate of the 2 groups. Musculoskeletal score (MSTS) was used to evaluate limb function in the surgical group at 2 months after the treatment.</p></sec><sec id="s2_4"><title>2.4. Statistical Processing</title><p>All data were processed by SPSS20.0 statistical software, measurement data comparison was by t test, count data comparison was by t test, survival comparison was by Kaplan-Meier survival analysis, and P &lt; 0.05 was considered statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><p>General clinical data and admission evaluation of all patients are shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>Outcomes:</p><p>The 14 patients in the surgical group, 13 patients achieved full load after operation, and the time of starting weight-bearing was 1 week and the time of full load was 2 - 4 weeks; 1 patient was complicated with cardiopulmonary failure after surgery at 36 days after surgery, who died of multiple organ failure and failed to achieve weight bearing. (2) of the 17 patients in the conservative group. 5 patients achieved partial weight-bearing until the end of follow-up. The time for partial weight-bearing was 8 - 9 weeks. 12 patients remained in bed or wheelchair transfer until death. None of the conservative group achieves full weight-bearing. Three patients in the conservative group died within 2 months and did not achieve a 2-month follow-up after fracture. Detail outcome was shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>At 2 months after treatment, the KPS score of the surgical group was higher than that of the conservative group (61.43 &#177; 19.56 vs. 27.64 &#177; 17.15, P &lt; 0.05), and the VAS score of the survivors of the surgical group was lower than that of the conservative group (2.92 &#177; 0.64 vs. 5.79 &#177; 0.89, P &lt; 0.05). <xref ref-type="fig" rid="fig1">Figure 1</xref> showed</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> General clinical information and admission evaluation of patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >Gender</th><th align="center" valign="middle" >Age</th><th align="center" valign="middle" >Fracture site</th><th align="center" valign="middle" >Primary tumor</th><th align="center" valign="middle" >KPS while admitted</th><th align="center" valign="middle" >VAS while admitted</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >liver</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >gastric</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >breast</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >colorectal</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >gastric</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >breast</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >gastric</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >breast</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >colorectal</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >breast</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >liver</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >breast</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >gastric</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >liver</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >gastric</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >26</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >breast</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >28</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >breast</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >29</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >colorectal</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >lung</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >31</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >L</td><td align="center" valign="middle" >liver</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >7</td></tr></tbody></table></table-wrap><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Detail outcomes of the two groups</title></caption><table-wrap id="2_1"><table><tbody><thead><tr><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >KPS at 2M</th><th align="center" valign="middle" >VAS at 2 M of survivor</th><th align="center" valign="middle" >Survival time after fracture (M)</th><th align="center" valign="middle" >Partial weight bearing (W)</th><th align="center" valign="middle" >Full load (W)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr></tbody></table></table-wrap><table-wrap id="2_2"><table><tbody><thead><tr><th align="center" valign="middle" >3</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" >60</th><th align="center" valign="middle" >3</th><th align="center" valign="middle" >9</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" >3</th></tr></thead><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >&gt;28</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >26</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >28</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >29</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >31</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></table-wrap-group><p>that the median survival time and 6-month survival rate after fracture in the surgical group were higher than those in the conservative group (13M vs. 4M, 85.7% vs. 35.3%, P &lt; 0.05). Comparison and analysis of data between and within the two groups were shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>In the surgical group, 8 patients underwent femoral tumor segment resection united prosthesis replacement, 6 patients underwent femoral tumor segment and pelvic local lesion resection united prosthesis replacement and bone cement local filling, 13 patients survived after 2 months of the fracture. The MSTS score was 16 - 26, with an average score of 20.38 &#177; 0.93. One patient had poor gait and was corrected through rehabilitation exercise and brace wear. No infection, loose prosthesis, dislocation, fractures around the prosthesis was found.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison and analysis of data between and within two groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Group</th><th align="center" valign="middle"  colspan="4"  >KPS</th><th align="center" valign="middle"  colspan="4"  >VAS</th><th align="center" valign="middle"  rowspan="2"  >Survival rate at 6 M (%)</th></tr></thead><tr><td align="center" valign="middle" >White admitted</td><td align="center" valign="middle" >at 2 M</td><td align="center" valign="middle" >t value</td><td align="center" valign="middle" >P value</td><td align="center" valign="middle" >White admitted</td><td align="center" valign="middle" >at 2 M</td><td align="center" valign="middle" >t value</td><td align="center" valign="middle" >P value</td></tr><tr><td align="center" valign="middle" >Surgery</td><td align="center" valign="middle" >32.86 &#177; 4.69</td><td align="center" valign="middle" >61.43 &#177; 19.56</td><td align="center" valign="middle" >5.316</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >7.00 &#177; 0.31</td><td align="center" valign="middle" >2.92 &#177; 0.64</td><td align="center" valign="middle" >17.717</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >85.7</td></tr><tr><td align="center" valign="middle" >Conservative</td><td align="center" valign="middle" >31.76 &#177; 3.93</td><td align="center" valign="middle" >27.64 &#177; 17.15</td><td align="center" valign="middle" >0.965</td><td align="center" valign="middle" >0.347</td><td align="center" valign="middle" >6.82 &#177; 0.64</td><td align="center" valign="middle" >5.79 &#177; 0.89</td><td align="center" valign="middle" >3.775</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >35.3</td></tr><tr><td align="center" valign="middle" >t or χ<sup>2</sup> value</td><td align="center" valign="middle" >0.706</td><td align="center" valign="middle" >5.123</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.813</td><td align="center" valign="middle" >9.507</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >8.016</td></tr><tr><td align="center" valign="middle" >P value</td><td align="center" valign="middle" >0.486</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.422</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.005</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion and Conclusion</title><p>At present, many scholars agree that: for patients with pathological fractures caused by bone metastasis of malignant tumor, surgical measures are adopted aimed to improve the quality of life of patients during survival rather than prolonging their survival time [<xref ref-type="bibr" rid="scirp.102271-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref4">4</xref>]. But something different is seen to be found in this study. On the one hand, in terms of improving the quality of life, the results of this study confirm the above point of view. In the surgical group, most patients achieved full weight bearing in 2 - 4 weeks after the surgery, resuming a large part of self-care ability. After 2 months of treatment, the KPS score of the survivors was significantly higher than that of the conservative group, and the majority (10/13) was above 60 points, which means that most patients continue to receive standardized oncological radiotherapy, chemotherapy and other specialty treatments. On the contrary, the KPS of the majority of the control group is below 40 points, which mean that these patients not only have poor self-care ability, but also difficult to be carried out by standard oncological treatment. On the other hand, we conducted long-term follow-up on all patients after fracture treatment. Survival analysis found that the median survival or 6-month survival rate of patients treated by surgery was higher than that of the conservative group; pathological hip fractures caused by malignant tumor bone metastasis had very poor self-healing ability without surgical intervention [<xref ref-type="bibr" rid="scirp.102271-ref8">8</xref>]. We noticed that only 5 cases of the conservative group achieved partial weight-bearing during the observation period, and most of them died 2 - 3 months after the fracture. There may be two reasons contributed to the bad result of conservative treatment: first, long-term bed rest is prone to a variety of complications, such as pneumonia, decubitus, etc., which accelerates the death of patients with malignant tumors and hip fractures; second, patients with conservative treatment of hip fractures are difficult to take care of themselves, and the KPS is so low that the original oncology treatment cannot be performed. This means that good limb function reconstruction is not only the need to improve the quality of life of these patients, but also the necessary means to ensure the successful implementation of oncology treatment, maintain the life expectancy and even prolong to the survival period.</p><p>Various surgical reconstruction measures are available to the proximal femoral pathological fracture, including internal plate fixation, intramuscularly nail fixation, and endoparasitic reconstruction, etc. [<xref ref-type="bibr" rid="scirp.102271-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref12">12</xref>]. The prerequisites for successful internal fixation of the steel plate are very stringent. First, there must be enough cortical bone, so that enough stability can be obtained after the operation to allow early weight bearing; second, the joints must be complete and offer sufficient range of motion without pain during everyday activities. These are more difficult to implement for patients with malignant tumors, which greatly limit the application of a steel plate in these cases. Even if the above conditions are met, the place still has an internal fixation failure rate of more than 20% [<xref ref-type="bibr" rid="scirp.102271-ref13">13</xref>], and the second time operation is more complicated and the patient is poorly tolerated. Now the plate is more inclined to preventive fixation of bone metastatic cancer [<xref ref-type="bibr" rid="scirp.102271-ref14">14</xref>]. intracellular fixation has better photomechanical advantages than steel plates, but two aspects need to consider: firstly, the process of nail placement can easily bring tumor cells to the distal side, causing new metastases and may led to another fracture [<xref ref-type="bibr" rid="scirp.102271-ref12">12</xref>]; secondary, it needs to balance the scraping of the tumor with the preservation of bone to obtain sufficient support, otherwise, little support will easily cause the stress to concentrate on the intermediate nail, leading to the loosening or even breaking of intramuscularly nail. Regardless of the plate or intramuscularly nail fixation, for patients with malignant tumors, the problem of slow healing or even non-healing must be considered [<xref ref-type="bibr" rid="scirp.102271-ref8">8</xref>], which will make it difficult for patients to fully relieve their pain and fail to achieve the purpose of surgery. Artificial enterolithiasis reconstruction is favored by clinicians because of its advantages of faster pain relief. Little needs to focus on bone preservation problems, and early weight-bearing allowance. Many scholars regard it as the most suitable functional reconstruction method for pathological fractures of the proximal femur caused by metastasis of malignant tumors [<xref ref-type="bibr" rid="scirp.102271-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.102271-ref16">16</xref>]. In this study, all the operation of the surgical group was successfully finished. Except for one patient who died of multiple organ failure in a short period of time, all other patients went back to the ground within 1 week and achieved full weight bearing within 2 - 4 weeks. MSTS average score is 20.38 &#177; 0.93 for the 13 survivors, reaching about 70% of normal limb function and meeting the need for self-care. Furthermore, the operation is safe and can be tolerable for most patients.</p><p>Although endocarditis reconstruction has advantages for these patients, the potential risks should also be obvious. The serious complications, which are disastrous, are loosening of the prosthesis and infection in the long-term [<xref ref-type="bibr" rid="scirp.102271-ref12">12</xref>]. These complications were not found in this study for two possible reasons: firstly, the sample size of this study is too small, and secondary, the survival time of the cases in this study was generally short, did not reaching the time of the above complications. It needs to be noticed that prosthesis dislocation and gait abnormalities are more likely to occur after prosthesis replacement due to extensive tissue dissection, injury, and resection [<xref ref-type="bibr" rid="scirp.102271-ref17">17</xref>]. No dislocation cases have been seen in this study, but 1 case of postoperative gait abnormalities is observed, which is worth noting. We believe that this type of reconstruction surgery has the following main points: 1) Pay attention to the improvement of preoperative examination, preoperative CT or MR can better help the planning of the tumor segment resection range, but it is still difficult to determine the resection range and the size of the prosthesis very accurately, so It is necessary to prepare multiple models of prostheses. And the preoperative design of 3D printing assisted personalized prosthesis is more advantageous in this regard and worth further study. 2) The resection of the tumor segment should be able to include a small amount of normal bone tissue to reduce the local recurrence rate [<xref ref-type="bibr" rid="scirp.102271-ref18">18</xref>], and normal bone tissue is conducive to early bonding of the prosthesis and bone and are beneficial to avoid the occurrence of fractures around the prosthesis. 3) Using the bone cement properly. Bone cement can be used as an adhesive to fix the prosthesis in a short period of time during tumor prosthesis replacement, and can also be used as a filler to make up for the defective bone, especially when the pelvis and acetabulum were invaded so that it is need to be scraped. Bone cement can greatly increase the stability of the prosthesis. In addition, the exothermic effect of bone cement solidification also has a certain killing effect on residual tumor cells, reducing local recurrence [<xref ref-type="bibr" rid="scirp.102271-ref19">19</xref>]. In this study, bone cement was used as a filler to fill the cavity after acetabular lesions were scraped in 6 cases. After surgery, the patients can still go to the ground normally and birth weight, and the effect is satisfactory. 4) Pay attention to the protection and reconstruction of soft tissue. When it is inevitable to remove part of the invaded soft tissue, try to leave the suture joint capsule as far as possible. If it cannot be left, postoperative orthopedic shoes or braces should be fixed. The method adopted by Guo Wei et al. [<xref ref-type="bibr" rid="scirp.102271-ref20">20</xref>] show the gluteus medius and gluteus minor tendons to the great trochanter of the prosthesis are worth learning. It is necessary to overlap and tightly stitch the remaining abductor muscles with the lateral femoral muscles to form a “sleeve” to protect the proximal prosthesis and maintain tension.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Zheng, W.K., Tang, J.F., Xiao, W.D. and Cai, W.S. (2020) Treatment of Pathological Fractures of the Proximal Femur Due to Advanced Metastasis of Highly Malignant Tumors: A Clinical Controlled Study of Enterostenosis Reconstruction and Conservative Treatment. Journal of Biosciences and Medicines, 8, 127-137. https://doi.org/10.4236/jbm.2020.88012</p></sec></body><back><ref-list><title>References</title><ref id="scirp.102271-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">He, Z.S., Bai, J.P., et al. (2010) Surgical Treatment of Pathological Fracture in 20 Patients with Proximal Femoral Metastatic Tumor. Chinese Journal of Bone Tumor and Bone Disease, 9, 492-494.</mixed-citation></ref><ref id="scirp.102271-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Jacofsky, D.J. and Haidukewych, G.J. (2004) Management of Pathologic Fractures of the Proximal Femur: State of the Art. Journal of Orthopaedic Trauma, 18, 459-469. https://doi.org/10.1097/00005131-200408000-00013</mixed-citation></ref><ref id="scirp.102271-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Calabro, T., ROOyen, R.V., Piraino, I., et al. (2016) Reconstruction of the Proximal Femur with a Modular Resection Prosthesis. European Journal of Orthopaedic Surgery and Traumatology, 26, 415-421. https://doi.org/10.1007/s00590-016-1764-0</mixed-citation></ref><ref id="scirp.102271-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Wang, F., Yang, X.G., Liu, Y.H., et al. (2017) Effectiveness of Modular Intercalary Endoprosthesis for Femoral Metastatic Pathological Fracture. Chinese Journal of Geriatric Orthopaedics and Rehabilitation (Electronic Edition), 3, 197-204.</mixed-citation></ref><ref id="scirp.102271-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Peterson, J.R., Decilveo, A.P., O’connor, I.T., et al. (2017) What Are the Functional Results and Complications with Long Term Hemiarthroplasty in Patients with Metastases to the Proximal Femur? Clinical Orthopaedics and Related Research, 475, 745-756. https://doi.org/10.1007/s11999-016-4810-7</mixed-citation></ref><ref id="scirp.102271-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Zoccali, C., Attala, D., Uccio, A.S.D., et al. (2017) The Dual Mobility Cup in Muscular Skeletal Oncology: Rationale and Indications. International Orthopaedics, 41, 447-453. https://doi.org/10.1007/s00264-017-3407-4</mixed-citation></ref><ref id="scirp.102271-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Van Der Linden, Y.M., Dijkstra, S.P., Vonk, E.J., et al. (2005) Prediction of Survival in Patients with Metastases in the Spinal Column—Results Based on a Randomized Trial of Radiotherapy. Cancer, 103, 320-328. https://doi.org/10.1002/cncr.20756</mixed-citation></ref><ref id="scirp.102271-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sarahrudi, K., Grdtbauer, M., Piatzer, P., et al. (2009) Surgical Treatment of Metastases Fractures of the Femur: A Retrospective Analysis of 142 Patients. The Journal of Trauma, 66, 1158-1163. https://doi.org/10.1097/TA.0b013e3181622bca</mixed-citation></ref><ref id="scirp.102271-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Harvey, N., Ahlmann, E.R., Auison, D.C., et al. (2012) Endoprostheses Last Longer than Intramedullary Devices in Proximal Femur Metastases. Clinical Orthopaedics and Related Research, 470, 684-691. https://doi.org/10.1007/s11999-011-2038-0</mixed-citation></ref><ref id="scirp.102271-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wang, S.F. and Xiong, J. (2009) Progress in the Treatment of Metastatic Carcinoma of the Proximal Femur. Chinese Journal of Bone Tumor and Bone Disease, 8, 370-375.</mixed-citation></ref><ref id="scirp.102271-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Wang, S.F., Xiong, J., Luo, D.S., et al. (2009) Surgical Management of Metastasis in Proximai Femur. Journal of Practical Orthopaedics, 15, 895-898.</mixed-citation></ref><ref id="scirp.102271-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y.S. and Shang, G.N. (2018) Surgical Treatment of Pathological Fracture of Long Bone Metastases of Lower Extremities. Chinese Journal of Surgical Oncology, 10, 77-80.</mixed-citation></ref><ref id="scirp.102271-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Yazawa, J., Frassica, F.J., Chao, E.F., et al. (1990) Metastatic Bone Disease. A Study of the Surgical Treatment of 166 Pathologic Humeral and Femoral Fractures. Journal of Clinical Orthopaedics, 251, 213-219. https://doi.org/10.1097/00003086-199002000-00036</mixed-citation></ref><ref id="scirp.102271-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Yang, Y., Yang, Y.L. and Guo, W. (2011) 59 Cases of Retrospective Analysis of Surgical Treatment of Humeral Metastatic Carcinoma. Journal of Peking University (Medical Edition), 43, 681-685.</mixed-citation></ref><ref id="scirp.102271-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Steensma, M., BoIand, P.J., Morris, C.D., et al. (2012) Endoprosthetic Treatment Is More Durable for Pathologic Proximal Femur Fractures. Clinical Orthopaedics and Related Research, 470, 920-926. https://doi.org/10.1007/s11999-011-2047-z</mixed-citation></ref><ref id="scirp.102271-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Guzik, G. (2016) Treatment Outcomes and Quality of Life after the Implantation of Modular Prostheses of the Proximal Femur in Patients with Cancer Metastases. Ortopedia Traumatologia Rehabilitacja, 18, 231-238. https://doi.org/10.5604/15093492.1212867</mixed-citation></ref><ref id="scirp.102271-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Chen, K., Liang, W.Q. and Cai, Z.D. (2010) Endoprosthetic Proximal Femoral Replacement for 37 Patients with Proximal Femoral Metastatic Tumor in One Institute: Retrospective Analysis within One Year. Journal of Clinical Rehabilitative Tissue Engineering Research, 14, 5551-5554.</mixed-citation></ref><ref id="scirp.102271-ref18"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names> W.B. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>Treatment Strategies for Bone Metastatic Tumors</article-title><source> Journal of Practical Oncology</source><volume> 23</volume>,<fpage> 290</fpage>-<lpage>293</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.102271-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Houdek, M.T., Watts, C.D., Wyles, C.C., et al. (2016) Functional and Oncologic Outcome of Cemented Endoprosthesis for Malignant Proximal Femorai Tumor. Journal of Surgical Oncology, 114, 501-506. https://doi.org/10.1002/jso.24339</mixed-citation></ref><ref id="scirp.102271-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Guo, W., Yang, Y., Tang, X.D., et al. (2007) Endoprosthetic Reconstruction after Resection of the Tumor of the Proximal Femur. Chinese Journal of Surgery, 45, 657-660.</mixed-citation></ref></ref-list></back></article>